Investigational Site Number : 2460040
Helsinki 00029 HUS
0 studies enrolling now · 1 studies all time
What they study most
Juvenile Idiopathic Arthritis
Studies at this site
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
— Completed